Children's Cancer Caring CenterChildren's Cancer Caring Center

Critical Shortage in Leukemia Drug
Published on Monday, February 20, 2012 by

Medication used to treat the most common form of childhood leukemia is in short supply, adding to the largest nationwide shortage of critical lifesaving hospital medications in nearly a decade.

All five pharmaceutical companies that make the injection drug methotrexate, which treats acute lymphoblastic leukemia by slowing the growth of cancer cells, have either slowed and stopped manufacturing of the drug, according to the U.S. Food and Drug Administration. The companies have cited high demand or manufacturing delays as reasons for the shortage.

If the shortage continues, physicians and pharmacists fear thousands of children will be left without lifesaving treatment.  <Read More>

28 cancer medications are in short supply

Doctors urge drugmakers to boost production

What’s causing the shortage

Rules force hospitals to discard scarce drugs

How drug shortage may affect the future of cancer care

No profit in kids cancer drugs

Doctors have long warned about impending shortages

Comments are closed.